Australia's cancer advisory agency "gathers momentum":
This article was originally published in Clinica
Executive Summary
Australia has announced the members of its new cancer advisory council, Cancer Australia. "It is an encouraging sign that the establishment of Cancer Australia is gathering momentum," said Professor Alan Coates, CEO of The Cancer Council of Australia. The group comprises leading cancer clinicians, healthcare administrators and experts from a number of other fields who can provide advice from a variety of perspectives on policy direction and governance. Praising the selection, Professor Coates said the group promised to "make a valuable contribution to improved cancer control". The bill for Cancer Australia was introduced to parliament in February. The government has pledged Aus$13.7m (US$10m) over five years for the setting up of the agency.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.